Dr. Bhaarat

Associate Consultant - Medical Onco & Haemato Oncology Cancer Institute



Successfully done transplant for Acute leukemia , Lymphoma myeloma and aplastic anemia.

Participated in 100+ Bone marrow transplant procedures including Autologous, MSD-Allogenic, MUD-Allogenic and Haplo-identical HSCT.

Expertise in diagnosing and treating blood disorders like ITP /ANEMIA/ TTP/HEMOLYTIC ANEMIA/THALASSEMIA AND OTHER BLOOD DISORDER.

Dr. Bhaarat is a Associate Consultant Hemato-Oncology in Medanta Gurgaon . He joined Medanta Gurgaon in Oct 21. He has successfully treated patients with lymphoma, leukemia, myeloma, and other blood disorders, as well as performed stem cell transplants for lymphoma, myeloma, and leukemia. He had completed DrNB Hemat-Oncology from (2018-2021) Rajiv Gandhi Cancer Institute & Research Centre, New Delhi under Dr Dinesh Bhurani , Dr Rayaz Ahmed and Dr Narendra Agrawal followed by Attending consultancy at same institute. He is skilled in bone marrow aspiration and biopsy, lumbar puncture and intrathecal chemotherapy, PICC line insertion. He has been involved as Co-Principal Investigator for various clinical trials relating to Myeloma and CLL and hemato-oncology patients.

Medical Qualifications

DrNB Clinical HematologyRajiv Gandhi Cancer Institute & Research Centre New Delhi2018-2021
MD MedicineSms Hospital, Jaipur , Rajasthan2014-2017
M.B.B.SDr. Sn Medical College Jodhpur Rajasthan2008-2014

Specialization and Expertise

  • Blood cancers like Acute leukemia, Lymphoma, Multiple Myeloma and others
  • Expertise in diagnosing and treating blood disorders like Anemia/ Aplastic Anemia/ ITP / TTP/ Hemolytic Anemia/Thalassemia and Other Blood Disorder
  • Bone Marrow Transplant for Acute Leukemia, Lymphoma Myeloma and Aplastic Anemia
  • Thrmobosis and bleeding disorders

Memberships & Certifications

  • Life member Association of Physicians India

Awards & Accomplishments

  • Completed (Dana- Farber Cancer Institute -Acute Lymphoblastic Leukemia)Preceptorship Program


  • Acute pancreatitis in Thalassemia post allogeneic stem cell transplant with Cyclosporine-A as a possible etiology: a report of two cases International Journal of Clinical Images and Medical Reviews :   1,
    Click here for Publications Link
  • Individualized AML Induction with Venetoclax Based Therapy in Unfit Treatment Naïve Patients Aged ≤ 60 Years: A Real World Perspective from India :   2,
    Click here for Publications Link
  • An “impossible” harvest–GCSF-induced immune thrombocytopenia in an autologous stem cell transplant recipient with multiple myeloma :   3,
    Click here for Publications Link
  • Retrospective Study of Carfilzomib-Pomalidomide-Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients in a Tertiary Care Hospital in India :   4,
    Click here for Publications Link